Age, tumor type, tumor stage, surgery history, radiotherapy history, diabetes, hypertension, smoking history, alcohol use, body mass index, anti-PD-1 drugs, first-line treatment or not, whether combined with chemotherapy or molecular targeted therapy, LIPI score and other effects on PFS were not statistically significant. This evidence concerns the gene PDCD1 and hypertensive disorder.